Disorders of prolactin secretion

被引:66
作者
Molitch, ME [1 ]
机构
[1] Northwestern Univ, Sch Med, Ctr Endocrinol Metab & Mol Med, Chicago, IL 60611 USA
关键词
D O I
10.1016/S0889-8529(05)70203-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolactinomas are a common cause of reproductive or sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history and physical examination, routine chemistries and a thyroid stimulating hormone, imaging with MR imaging or CT will delineate the size and extent of the tumor. Medical therapy is the initial treatment of choice. When infertility is the primary indication for treatment, bromocriptine use has an extensive safety record and is preferred; however, for other indications, cabergoline seems to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective.
引用
收藏
页码:585 / +
页数:27
相关论文
共 134 条
[1]   Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma - Case report [J].
Albuquerque, FC ;
Hinton, DR ;
Weiss, MH .
JOURNAL OF NEUROSURGERY, 1998, 89 (06) :1043-1046
[2]  
ANDREOTTI AC, 1995, J CLIN ENDOCR METAB, V80, P341
[3]   DYNAMICS OF PROLACTIN SECRETION IN PATIENTS WITH HYPOPITUITARISM AND PITUITARY MACROADENOMAS [J].
ARAFAH, BM ;
NEKL, KE ;
GOLD, RS ;
SELMAN, WR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3507-3512
[4]   VASOACTIVE INTESTINAL POLYPEPTIDE IS SYNTHESIZED IN ANTERIOR-PITUITARY TISSUE [J].
ARNAOUT, MA ;
GARTHWAITE, TL ;
MARTINSON, DR ;
HAGEN, TC .
ENDOCRINOLOGY, 1986, 119 (05) :2052-2057
[5]   Giant pituitary prolactinoma with falsely low serum prolactin: The pitfall of the "high-dose hook effect": Case report [J].
Barkan, AL ;
Chandler, WF .
NEUROSURGERY, 1998, 42 (04) :913-915
[6]   Abnormal transduction mechanisms in pituitary adenomas [J].
Barlier, A ;
PellegriniBouiller, I ;
Caccavelli, L ;
Gunz, G ;
MorangeRamos, I ;
Jaquet, P ;
Enjalbert, A .
HORMONE RESEARCH, 1997, 47 (4-6) :227-234
[7]   CLINICAL AND PATHOLOGICAL EFFECTS OF BROMOCRIPTINE ON PROLACTIN-SECRETING AND OTHER PITUITARY-TUMORS [J].
BARROW, DL ;
TINDALL, GT ;
KOVACS, K ;
THORNER, MO ;
HORVATH, E ;
HOFFMAN, JC .
JOURNAL OF NEUROSURGERY, 1984, 60 (01) :1-7
[8]   FACTORS IN THE OUTCOME OF TRANS-SPHENOIDAL SURGERY FOR PROLACTINOMA AND NONFUNCTIONING PITUITARY-TUMOR, INCLUDING PREOPERATIVE BROMOCRIPTINE THERAPY [J].
BEVAN, JS ;
ADAMS, CBT ;
BURKE, CW ;
MORTON, KE ;
MOLYNEUX, AJ ;
MOORE, RA ;
ESIRI, MM .
CLINICAL ENDOCRINOLOGY, 1987, 26 (05) :541-556
[9]   Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline [J].
Biller, BMK ;
Molitch, ME ;
Vance, ML ;
Cannistraro, KB ;
Davis, KR ;
Simons, JA ;
Schoenfelder, JR ;
Klibanski, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2338-2343
[10]   COMPUTED TOMOGRAPHIC DEMONSTRATION OF THE EFFECTS OF BROMOCRIPTINE ON PITUITARY MICROADENOMA SIZE [J].
BONNEVILLE, JF ;
POULIGNOT, D ;
CATTIN, F ;
COUTURIER, M ;
MOLLET, E ;
DIETEMANN, JL .
RADIOLOGY, 1982, 143 (02) :451-455